Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 9, Pages e107434
Publisher
Public Library of Science (PLoS)
Online
2014-09-11
DOI
10.1371/journal.pone.0107434
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exploring the Effect of Sequence Length and Composition on Allele-Selective Inhibition of Human Huntingtin Expression by Single-Stranded Silencing RNAs
- (2014) Jiaxin Hu et al. Nucleic Acid Therapeutics
- Allele-Selective Inhibition of Expression of Huntingtin and Ataxin-3 by RNA Duplexes Containing Unlocked Nucleic Acid Substitutions
- (2013) Yuichiro Aiba et al. BIOCHEMISTRY
- Treatment of Huntington Disease
- (2013) Aleksandar Videnovic Current Treatment Options in Neurology
- CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease
- (2013) Alicia Semaka et al. JOURNAL OF MEDICAL GENETICS
- An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
- (2013) Timothy M Miller et al. LANCET NEUROLOGY
- Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk
- (2013) Emily R. Fisher et al. MOVEMENT DISORDERS
- ss-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategy
- (2013) Jing Liu et al. NUCLEIC ACIDS RESEARCH
- RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expression
- (2013) J. Liu et al. NUCLEIC ACIDS RESEARCH
- Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS
- (2013) Michael E. Østergaard et al. NUCLEIC ACIDS RESEARCH
- Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression
- (2012) Dongbo Yu et al. CELL
- A fully humanized transgenic mouse model of Huntington disease
- (2012) Amber L. Southwell et al. HUMAN MOLECULAR GENETICS
- Assessing unintended hybridization-induced biological effects of oligonucleotides
- (2012) Morten Lindow et al. NATURE BIOTECHNOLOGY
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
- (2012) Holly B. Kordasiewicz et al. NEURON
- TricycloDNA-modified oligo-2′-deoxyribonucleotides reduce scavenger receptor B1 mRNA in hepatic and extra-hepatic tissues—a comparative study of oligonucleotide length, design and chemistry
- (2012) Sue Murray et al. NUCLEIC ACIDS RESEARCH
- Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases
- (2012) Amber L. Southwell et al. TRENDS IN MOLECULAR MEDICINE
- Silencing disease genes in the laboratory and the clinic
- (2011) Jonathan K Watts et al. JOURNAL OF PATHOLOGY
- Development of biomarkers for Huntington's disease
- (2011) David W Weir et al. LANCET NEUROLOGY
- Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin
- (2011) Jeffrey B Carroll et al. MOLECULAR THERAPY
- Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease
- (2011) Jodi L McBride et al. MOLECULAR THERAPY
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
- (2010) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- Allele-Selective Inhibition of MutantHuntingtinExpression with Antisense Oligonucleotides Targeting the Expanded CAG Repeat
- (2010) Keith T. Gagnon et al. BIOCHEMISTRY
- Allele-Selective Inhibition of Huntingtin Expression by Switching to an miRNA-like RNAi Mechanism
- (2010) Jiaxin Hu et al. CHEMISTRY & BIOLOGY
- Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
- (2010) Chiara Zuccato et al. PHYSIOLOGICAL REVIEWS
- Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
- (2010) Samuel Frank Neuropsychiatric Disease and Treatment
- CAG Expansion in the Huntington Disease Gene Is Associated with a Specific and Targetable Predisposing Haplogroup
- (2009) Simon C. Warby et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Sustained effects of nonallele-specificHuntingtinsilencing
- (2009) Valérie Drouet et al. ANNALS OF NEUROLOGY
- Allele-Selective Inhibition of Mutant Huntingtin by Peptide Nucleic Acid-Peptide Conjugates, Locked Nucleic Acid, and Small Interfering RNA
- (2009) Jiaxin Hu et al. Annals of the New York Academy of Sciences
- Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways
- (2009) Zhiqun Zhang et al. APOPTOSIS
- Five siRNAs Targeting Three SNPs May Provide Therapy for Three-Quarters of Huntington's Disease Patients
- (2009) Edith L. Pfister et al. CURRENT BIOLOGY
- A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference
- (2009) Maria Stella Lombardi et al. EXPERIMENTAL NEUROLOGY
- Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
- (2009) Ryan L Boudreau et al. MOLECULAR THERAPY
- Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs
- (2009) Jiaxin Hu et al. NATURE BIOTECHNOLOGY
- Improvement of RNA secondary structure prediction using RNase H cleavage and randomized oligonucleotides
- (2009) A. D. Kauffmann et al. NUCLEIC ACIDS RESEARCH
- Identification and Allele-Specific Silencing of the Mutant Huntingtin Allele in Huntington's Disease Patient-Derived Fibroblasts
- (2008) P.H.J. van Bilsen et al. HUMAN GENE THERAPY
- Short Antisense Oligonucleotides with Novel 2′−4′ Conformationaly Restricted Nucleoside Analogues Show Improved Potency without Increased Toxicity in Animals
- (2008) Punit P. Seth et al. JOURNAL OF MEDICINAL CHEMISTRY
- Allele-specific silencing of mutant Huntington’s disease gene
- (2008) Yu Zhang et al. JOURNAL OF NEUROCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now